MEDIA CALL: FDA’s Proposed Order on Phenylephrine - 11/7/2024

Поділитися
Вставка
  • Опубліковано 12 лис 2024
  • A media availability to discuss the FDA's proposal to end the use of oral phenylephrine as an active ingredient in over-the-counter (OTC) monograph drug products.
    On the call:
    • Peter Stein, M.D., director of the Office of New Drugs within the FDA’s Center for Drug Evaluation and Research
    • Theresa Michele, M.D., director of the Office of Nonprescription Drugs within the FDA’s Center for Drug Evaluation and Research

КОМЕНТАРІ •